Literature DB >> 2590614

Morphine metabolism in children.

I A Choonara1, P McKay, R Hain, A Rane.   

Abstract

1. The metabolism of morphine was studied in 12 children and nine premature neonates on a continuous infusion of morphine (10-360 micrograms kg-1 h-1). 2. The mean plasma clearance of morphine was significantly higher in children than neonates (25.7 and 4.7 ml min-1 kg-1, respectively) (P less than 0.01). 3. All the neonates and children had detectable concentrations of morphine-3-glucuronide (M3G) in plasma. All the children and five neonates had detectable concentrations of morphine-6-glucuronide (M6G) in plasma or urine. 4. The M3G/morphine ratios in plasma and urine, and M6G/morphine ratios in urine were significantly higher in children than neonates (P less than 0.01), suggesting that morphine glucuronidation capacity is enhanced after the neonatal period. 5. There was no difference in the M3G/M6G ratio in children and neonates, indicating a parallel development of both glucuronidation pathways.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2590614      PMCID: PMC1380022          DOI: 10.1111/j.1365-2125.1989.tb03548.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  24 in total

1.  Morphine-6-glucuronide has high affinity for the opioid receptor.

Authors:  C B Christensen; L N Jørgensen
Journal:  Pharmacol Toxicol       Date:  1987-01

2.  Analgesic activity of morphine-6-glucuronide.

Authors:  R Osborne; S Joel; D Trew; M Slevin
Journal:  Lancet       Date:  1988-04-09       Impact factor: 79.321

3.  Postoperative morphine infusion in newborn infants: assessment of disposition characteristics and safety.

Authors:  G Koren; W Butt; H Chinyanga; S Soldin; Y K Tan; K Pape
Journal:  J Pediatr       Date:  1985-12       Impact factor: 4.406

4.  Morphine pharmacokinetics in early infancy.

Authors:  A M Lynn; J T Slattery
Journal:  Anesthesiology       Date:  1987-02       Impact factor: 7.892

5.  Pain relief for the pediatric surgical patient.

Authors:  N M Dilworth; A MacKellar
Journal:  J Pediatr Surg       Date:  1987-03       Impact factor: 2.545

6.  Variation in morphine pharmacokinetics in children with cancer.

Authors:  M C Nahata; A W Miser; J S Miser; R H Reuning
Journal:  Dev Pharmacol Ther       Date:  1985

7.  Pharmacokinetics of single-dose i.v. morphine in normal volunteers and patients with end-stage renal failure.

Authors:  A R Aitkenhead; M Vater; K Achola; C M Cooper; G Smith
Journal:  Br J Anaesth       Date:  1984-08       Impact factor: 9.166

8.  Pharmacokinetics of intravenous morphine in balanced anesthesia: studies in children.

Authors:  H Vandenberghe; S Mac Leod; H Chinyanga; L Endrenyi; S Soldin
Journal:  Drug Metab Rev       Date:  1983       Impact factor: 4.518

9.  Kinetics of morphine in patients with renal failure.

Authors:  J Säwe; I Odar-Cederlöf
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

10.  Morphine pharmacokinetics in renal failure.

Authors:  M Chauvin; P Sandouk; J M Scherrmann; R Farinotti; P Strumza; P Duvaldestin
Journal:  Anesthesiology       Date:  1987-03       Impact factor: 7.892

View more
  36 in total

1.  Morphine induced allodynia in a child with brain tumour.

Authors:  S Heger; C Maier; K Otter; U Helwig; M Suttorp
Journal:  BMJ       Date:  1999-09-04

2.  Morphine induced allodynia in child with brain tumour. Signs are more likely to have been due to underlying medical condition.

Authors:  I L Marples; P Murray
Journal:  BMJ       Date:  2000-02-05

Review 3.  Glucuronidation in humans. Pharmacogenetic and developmental aspects.

Authors:  S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

4.  Use of sedatives and muscle relaxants in newborn babies receiving mechanical ventilation.

Authors:  M I Levene; M W Quinn
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

Review 5.  Strong opioids in pediatric palliative medicine.

Authors:  Richard D W Hain; Angela Miser; Mary Devins; W Hamish B Wallace
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 6.  Developmental pharmacokinetics in pediatric populations.

Authors:  Hong Lu; Sara Rosenbaum
Journal:  J Pediatr Pharmacol Ther       Date:  2014 Oct-Dec

Review 7.  Clinical pharmacokinetics and pharmacodynamics of opioid analgesics in infants and children.

Authors:  K T Olkkola; K Hamunen; E L Maunuksela
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

8.  Infants and young children metabolise codeine to morphine. A study after single and repeated rectal administration.

Authors:  H Quiding; G L Olsson; L O Boreus; U Bondesson
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

Review 9.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

10.  Randomised, double blind trial of two loading dose regimens of diamorphine in ventilated newborn infants.

Authors:  D P Barker; J Simpson; M Pawula; D A Barrett; P N Shaw; N Rutter
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-07       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.